MCID: PLC002
MIFTS: 35

Plica Syndrome

Categories: Bone diseases

Aliases & Classifications for Plica Syndrome

MalaCards integrated aliases for Plica Syndrome:

Name: Plica Syndrome 12 15 70
Synovitis 44

Classifications:



External Ids:

Disease Ontology 12 DOID:12225
ICD9CM 34 727.83
MeSH 44 D013585
ICD10 32 M67.5
UMLS 70 C0878705

Summaries for Plica Syndrome

MalaCards based summary : Plica Syndrome, also known as synovitis, is related to pigmented villonodular synovitis and villonodular synovitis. An important gene associated with Plica Syndrome is PLGLB2 (Plasminogen Like B2). The drugs rituximab and Triamcinolone have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and endothelial.

Wikipedia : 73 Plica syndrome is a condition that occurs when a plica (a vestigial extension of the protective synovial... more...

Related Diseases for Plica Syndrome

Diseases related to Plica Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 431)
# Related Disease Score Top Affiliating Genes
1 pigmented villonodular synovitis 11.7
2 villonodular synovitis 11.6
3 remitting seronegative symmetrical synovitis with pitting edema 11.4
4 blau syndrome 11.3
5 sapho syndrome 11.3
6 noonan syndrome 1 11.3
7 gonococcal synovitis 11.2
8 camptodactyly-arthropathy-coxa vara-pericarditis syndrome 11.2
9 rheumatoid arthritis 11.2
10 talo-patello-scaphoid osteolysis, synovitis, and short fourth metacarpals 11.1
11 legg-calve-perthes disease 11.0
12 eosinophilic fasciitis 10.9
13 intermittent hydrarthrosis 10.9
14 noonan syndrome 4 10.9
15 jaccoud's syndrome 10.9
16 arthritis 10.8
17 osteoarthritis 10.8
18 arthropathy 10.7
19 bone inflammation disease 10.7
20 acne 10.6
21 hyperostosis 10.6
22 tenosynovitis 10.6
23 psoriatic arthritis 10.5
24 septic arthritis 10.5
25 osteomyelitis 10.5
26 temporal arteritis 10.4
27 juvenile rheumatoid arthritis 10.4
28 inflammatory spondylopathy 10.4
29 spondylitis 10.4
30 hemophilia 10.4
31 frozen shoulder 10.4
32 enthesopathy 10.4
33 bursitis 10.4
34 gout 10.4
35 spondyloarthropathy 1 10.4
36 tenosynovial giant cell tumor 10.3
37 synovial chondromatosis 10.3
38 osteoid osteoma 10.3
39 reactive arthritis 10.3
40 chondrocalcinosis 10.2
41 proteasome-associated autoinflammatory syndrome 1 10.2
42 osteonecrosis 10.2
43 pustulosis of palm and sole 10.2
44 psoriasis 10.2
45 autoimmune disease 10.2
46 carpal tunnel syndrome 10.2
47 sarcoidosis 1 10.2
48 triiodothyronine receptor auxiliary protein 10.2
49 hemophilic arthropathy 10.2
50 benign giant cell tumor 10.2

Graphical network of the top 20 diseases related to Plica Syndrome:



Diseases related to Plica Syndrome

Symptoms & Phenotypes for Plica Syndrome

Drugs & Therapeutics for Plica Syndrome

Drugs for Plica Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 116)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
rituximab Approved Phase 4 174722-31-7 10201696
2
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
3
mometasone furoate Approved, Investigational, Vet_approved Phase 4 83919-23-7
4 Adrenocorticotropic Hormone Phase 4
5 Melanocyte-Stimulating Hormones Phase 4
6 beta-Endorphin Phase 4
7 Anti-Inflammatory Agents Phase 4
8 Triamcinolone diacetate Phase 4
9 triamcinolone acetonide Phase 4
10 Triamcinolone hexacetonide Phase 4
11 Hormone Antagonists Phase 4
12 glucocorticoids Phase 4
13 Hormones Phase 4
14 Coagulants Phase 4
15 Factor VIII Phase 4
16 BAX 855 Phase 4
17
Etanercept Approved, Investigational Phase 3 185243-69-0
18
Abatacept Approved Phase 3 332348-12-6 10237
19
Certolizumab pegol Approved Phase 3 428863-50-7
20
Sargramostim Approved, Investigational Phase 3 123774-72-1, 83869-56-1
21
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3 1177-87-3
22
Lidocaine Approved, Vet_approved Phase 3 137-58-6 3676
23
Ketorolac Approved Phase 3 74103-06-3, 66635-83-4 3826
24
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
25
Chondroitin Phase 3 9007-27-6 14389182
26 Analgesics, Non-Narcotic Phase 3
27 Gastrointestinal Agents Phase 3
28 Analgesics Phase 3
29 Anti-Inflammatory Agents, Non-Steroidal Phase 3
30 Analgesics, Opioid Phase 3
31 Cyclooxygenase Inhibitors Phase 3
32 Antineoplastic Agents, Hormonal Phase 3
33 Liver Extracts Phase 3
34 Antiemetics Phase 3
35 Ketorolac Tromethamine Phase 3
36 BB 1101 Phase 3
37
Fludarabine Approved Phase 2 21679-14-1, 75607-67-9 30751
38
Olaparib Approved Phase 2 763113-22-0 23725625
39
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
40
Everolimus Approved Phase 2 159351-69-6 6442177 70789204
41
Durvalumab Approved, Investigational Phase 2 1428935-60-7
42
Lapatinib Approved, Investigational Phase 2 231277-92-2, 388082-78-8 208908 9941095
43
Prednisolone acetate Approved, Vet_approved Phase 2 52-21-1
44
Methylprednisolone Approved, Vet_approved Phase 2 83-43-2 6741
45
Prednisolone Approved, Vet_approved Phase 2 50-24-8 5755
46
Prednisolone phosphate Approved, Vet_approved Phase 2 302-25-0
47
Methylprednisolone hemisuccinate Approved Phase 2 2921-57-5
48
Vitamin C Approved, Nutraceutical Phase 2 50-81-7 5785 54670067
49
Tremelimumab Investigational Phase 2 745013-59-6
50
Prednisolone hemisuccinate Experimental Phase 2 2920-86-7

Interventional clinical trials:

(show top 50) (show all 63)
# Name Status NCT ID Phase Drugs
1 Targeting Synovitis in Early Rheumatoid Arthritis (TaSER). Intensive Management of Early Rheumatoid Arthritis Using Either Clinical or Musculoskeletal Ultrasound Assessment of Synovitis - a Randomised Study With Blinded Outcome Assessments Unknown status NCT00920478 Phase 4
2 Dosing of Intra-articular Triamcinolone Hexacetonide for Knee Synovitis in Chronic Polyarthritis Unknown status NCT02437461 Phase 4 Triamcinolone hexacetonide
3 Aiming for Remission in Rheumatoid Arthritis: a Randomized Trial Examining the Benefit of Ultrasonography in a Clinical TIght Control Regimen Completed NCT01205854 Phase 4
4 A Randomized, Double-blind, Placebo-controlled Study to Assess Efficacy of Tocilizumab+Non-biological DMARD in Reducing Synovitis as Measured by MRI at 12 Weeks After Initiation of Treatment in Patients With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Non-biological DMARDs Completed NCT01034397 Phase 4 tocilizumab [RoActemra/Actemra];placebo;non-biological DMARDs
5 Pilot Study to Evaluate the Effect of Mabthera in Combination With MTX in the Inhibition of Progression of Synovitis, Bone Marrow Edema, and Erosions Evaluated by Magnetic Resonance Imaging (MRI) in the Hand of Patients With Rheumatoid Arthritis. Completed NCT00502853 Phase 4 rituximab [MabThera/Rituxan];Methotrexate
6 Study of The Effect of Corticotrophin in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients From a Clinical and Structural Perspective As Measured by a Clinical Disease Activity Index Score and Bone Edema, Synovitis and Erosions on Magnetic Resonance Imaging Completed NCT01948388 Phase 4 corticotrophin 80 units
7 Injection After Arthroscopic Partial Meniscectomy Recruiting NCT04641351 Phase 4 Zilretta Injectable Product or Placebo
8 Intensive Replacement Treatment in Haemophilia Patients With Synovitis Not yet recruiting NCT04784988 Phase 4 Adynovate;plasma derived or recombinant products containing FVIII
9 Adipose Derived Stromal Cell Transplantation as an Adjunct to Arthroscopy in Treatment of Effusion Synovitis of the Early Degenerative Knee Suspended NCT03922490 Phase 4
10 Open Label Study to Describe the Effect of Tocilizumab in Combination With MTX in the Evolution of Articular Damage (Synovitis/Osteitis and Erosions) Evaluated by MRI in the Hand of Patients With Moderate to Severe Rheumatoid Arthritis (RA) and Inadequate Response to Non-biological DMARDs Withdrawn NCT01878318 Phase 4 methotrexate;tocilizumab [RoActemra/Actemra]
11 Study of the Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee Completed NCT00604539 Phase 3 Chondroitin sulphate (Condrosan);Placebo
12 A Phase IIIB Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Assess Short-term Changes in Synovitis and Structural Damage Outcomes in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate, Treated With Abatacept Versus Placebo on a Background Therapy With Methotrexate Completed NCT00420199 Phase 3 Abatacept;Placebo
13 The Effect of Certolizumab Pegol in Combination With Methotrexate on MRI Synovitis and Bone Edema and Patient Reported Outcomes as Measured Using an Automated Visit Manager System in Moderate to Severe Rheumatoid Arthritis Patients Completed NCT01213017 Phase 3 certolizumab pegol
14 Open Label, Multicentric Phase IIIb Study to Evaluate the Effect of Tocilizumab in Combination With DMARDs in the Inhibition of Progression of Synovitis, Bone Marrow Edema, and Erosions Evaluated by Dedicated Magnetic Resonance Imaging (MRI) in the Hand of Patients With Rheumatoid Arthritis (RA) Completed NCT00996606 Phase 3 DMARDs;Tocilizumab
15 Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study for Evaluation of Efficacy and Safety of Etanercept Versus Intra-Articular Steroid Injection in Acute Synovitis Completed NCT00522184 Phase 3
16 A Double-blind, Randomized, Placebo-controlled Phase 3 Study of Orally Administered PLX3397 in Subjects With Pigmented Villonodular Synovitis or Giant Cell Tumor of the Tendon Sheath Active, not recruiting NCT02371369 Phase 3 Pexidartinib;Placebo
17 A Double-blinded, Prospective, Randomized, Controlled Trial Comparing Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders Terminated NCT02266433 Phase 3 Ketorolac;Dexamethasone
18 A Prospective Double-Blinded Clinical Trial Using Apatone®B for Care and Treatment of Proven Non-Infected Symptomatic Postoperative Total Joint Arthroplasties Completed NCT01272830 Phase 2 Placebo;Apatone®B
19 Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis: a Placebo Controlled, Single-Blind, Crossover-Trial, With Randomisation of Treatment Sequence Completed NCT00678782 Phase 2 etanercept;placebo
20 A Phase 1/2 Study of Cabiralizumab, an Anti-CSF1 Receptor Antibody, in Patients With Pigmented Villonodular Synovitis (PVNS)/ Diffuse Type Tenosynovial Giant Cell Tumor (Dt-TGCT) Completed NCT02471716 Phase 1, Phase 2
21 Phase II Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) Completed NCT01261429 Phase 2 Tasigna
22 A Phase II Randomized, Double -Blind, Placebo Controlled Study to Assess Safety, Tolerability and Effect on Tumor Size of MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) Completed NCT01643850 Phase 2 MCS110;Placebo
23 Impact of Rituximab on Magnetic Resonance Imaging Evidence of Synovitis and Bone Lesions in Patients With Moderate or Severe Rheumatoid Arthritis Completed NCT00425932 Phase 2
24 Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy Completed NCT00001677 Phase 2 Methotrexate;Fludarabine
25 A Multicenter Phase 1/2, Open-Label Study of DCC-3014 to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor Recruiting NCT03069469 Phase 1, Phase 2 DCC-3014
26 A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors Recruiting NCT02029001 Phase 2 Nilotinib (400 mg BID);Everolimus (10 mg QD);Sorafenib (400 mg BID);Lapatinib (1500 mg QD);Pazopanib (800 mg QD);Olaparib (300 mg BID)
27 MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE Recruiting NCT03355482 Phase 2 Methylprednisolone;Placebos
28 A Multi-Center Single Agent Phase II Study of the Efficacy of Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor Active, not recruiting NCT01207492 Phase 2 nilotinib
29 An Adaptive, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee Not yet recruiting NCT04731675 Phase 2
30 Investigation of the Use of Positron Emission Tomography With 18F-FDG PET/CT for the Diagnosis of Synovitis in the Temporomandibular Joint Withdrawn NCT01471418 Phase 2 PET/CT with 18-FDG
31 A Pilot Study About the Safety and Efficacy of Intra-articular Bevacizumab (Avastin) for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis Recruiting NCT02060305 Phase 1 Bevacizumab intra-articular injection
32 A Phase 1 Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX73086 as a Single Agent in Subjects With Advanced Solid Tumors and in Subjects With Locally Advanced or Refractory Tenosynovial Giant Cell Tumor (TGCT) Terminated NCT02673736 Phase 1 PLX73086
33 The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission.Preliminary Study Unknown status NCT01050010
34 Medial Plica Syndrome of the Knee: Conservative Treatment Versus Arthroscopic Plica Resection - a Randomized Controlled Multicenter Trial Unknown status NCT02578589
35 Evaluation of the Effectiveness of Surgical Treatment of Villo-nodular Synovitis of the Hip in Children in a Retrospective Case Series Unknown status NCT03507933
36 Computer-Assisted Quantification of the Synovial Perfusion in Patients With Arthritis Using Two-Dimensional and Three-Dimensional Power Doppler Ultrasonography Unknown status NCT00903903
37 Musculoskeletal Ultrasound of the Ankles in Erysipelas-like Erythema of Familial Mediterranean Fever Unknown status NCT03917277
38 The Effect on Gait Pattern in Patients Receiving Arthroscopic Cartilage Regeneration Facilitating Procedure (ACRFP) for Treatment of Osteoarthritis Unknown status NCT03452423
39 A Clinical Study of Subclinical Enthesitis and Synovitis in Patients With Vulgaris Psoriasis Unknown status NCT02339636
40 Correlation of "Painless" Synovitis With Clinical, Laboratory and Radiological (X-ray, Sonography) Finds in Patients With Longstanding Rheumatoid Arthritis (RA). Unknown status NCT01639287
41 Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis Unknown status NCT01731262
42 Evaluation of the Role of Power Doppler Sonography in the Diagnosis of Hemophilic Joint Disease Completed NCT00212485
43 Fibromyalgia-like Joint/Muscle Pain and Synovitis in Non-celiac Wheat Sensitivity Patients Completed NCT03022513
44 Impact of Body Mass Index on the Agreement Between Ultrasound- and Clinical Assessments of Disease Activity in RA : Cross-sectionnal Study Completed NCT03004651
45 Quantitative Assessment of Synovitis and Therapy Response in Inflammatory Arthritis With Contrast Enhanced Ultrasound Completed NCT02902562
46 Comparison of the Frequency of Subclinic Synovitis in the Distal Interphalangeal Joints of the Hand in Psoriasis Patients Completed NCT04750993
47 Physiotherapy in the Treatment of Elbow Hemophilic Arthropathy: Manual Therapy vs Educational Physiotherapy. A Pilot Sudy Completed NCT02198040
48 Effectiveness of Manual Therapy and Educational Physiotherapy in the Treatment of Hemophilic Arthropathy of the Knee. A Randomized Pilot Study Completed NCT02198014
49 Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients Completed NCT00001679
50 The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis Completed NCT00001375

Search NIH Clinical Center for Plica Syndrome

Cochrane evidence based reviews: synovitis

Genetic Tests for Plica Syndrome

Anatomical Context for Plica Syndrome

MalaCards organs/tissues related to Plica Syndrome:

40
Bone, Bone Marrow, Endothelial, T Cells, Skin, Neutrophil, Monocytes

Publications for Plica Syndrome

Articles related to Plica Syndrome:

(show top 50) (show all 11337)
# Title Authors PMID Year
1
Synthesis and anti-rheumatoid arthritis activities of 3-(4-aminophenyl)-coumarin derivatives. 61
33557646 2021
2
The study of gp130/the inflammatory factors regulating osteoclast differentiation in rheumatoid arthritis. 61
33604457 2021
3
99mTc-MDP 3-Phase Bone Imaging in 3 Cases of Pigmented Villonodular Synovitis. 61
33630800 2021
4
Combination of magnesium ions and vitamin C alleviates synovitis and osteophyte formation in osteoarthritis of mice. 61
33210027 2021
5
cIAP2 expression and clinical significance in pigmented villonodular synovitis. 61
33599891 2021
6
Treatment of knee osteoarthritic pain with platelet-rich plasma: a systematic review of clinical studies. 61
33764185 2021
7
Rheumatoid arthritis: Extra-articular manifestations and comorbidities. 61
33609792 2021
8
[Rheumatoid arthritis of the hand : Part 2: Imaging]. 61
33728480 2021
9
Ultrasound characterization of the nail bed in patients with systemic lupus erythematosus. 61
33470159 2021
10
Fibromyalgia in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: prevalence and screening. 61
32949312 2021
11
[Rheumatoid arthritis of the hand : Part 1: Clinical aspects]. 61
33728481 2021
12
Carpal Tunnel Syndrome: A New Adverse Effect of Immune Checkpoint Inhibitors, 11 Cases. 61
33086341 2021
13
The lipopolysaccharide model for the experimental induction of transient lameness and synovitis in Standardbred horses. 61
33641810 2021
14
Expression profiles of long non-coding RNAs in the cartilage of patients with knee osteoarthritis and normal individuals. 61
33732338 2021
15
Ultrasound to identify SLE patients with musculoskeletal symptoms who respond best to therapy: The USEFUL longitudinal multicentre study. 61
33792659 2021
16
Does the timing of surgical intervention impact the clinical outcomes and overall duration of symptoms in frozen shoulder? 61
32750533 2021
17
Clinical characteristics of pediatric synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: the first Chinese case series from a single center. 61
32929648 2021
18
Tumours and tumour-like lesions of joints: Differential diagnoses in a paediatric population compared to adults. 61
33617297 2021
19
Association between Baseline Osteoarthritic Features on MR Imaging and Clinical Outcome after Genicular Artery Embolization for Knee Osteoarthritis. 61
33526342 2021
20
Oral Administration of a Chemically Modified Curcumin, TRB-N0224, Reduced Inflammatory Cytokines and Cartilage Erosion in a Rabbit ACL Transection Injury Model. 61
30486657 2021
21
Modified Stoppa Approach: Beyond Acetabular Fractures: A Report of 2 Cases. 61
33798123 2021
22
Serum Sp17 Autoantibody Serves as a Potential Specific Biomarker in Patients with SAPHO Syndrome. 61
33392854 2021
23
The Value of Musculoskeletal Ultrasound for Evaluation of Postinfectious Lyme Arthritis. 61
33790205 2021
24
An acquired plica-induced notch in the medial femoral condyle in a patient with medial patellar plica syndrome: a case report. 61
33761915 2021
25
Superb Microvascular Imaging in Assessment of Synovitis and Tenosynovitis in Juvenile Idiopathic Arthritis. 61
33661799 2021
26
Pigmented Villonodular Synovitis of the Hip in Patients Undergoing Total Hip Arthroplasty: A Retrospective Case-Controlled Analysis. 61
32978024 2021
27
Posterior ankle arthroscopy for posterior ankle synovitis with an enlarged posterior talar process caused by a cat bite or scratch: A case report. 61
33743253 2021
28
Coexistence of Sjögren syndrome in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A retrospective observational study. 61
33761629 2021
29
Overuse Elbow Injuries in Youth Gymnasts. 61
33780632 2021
30
Correction to: Validity and diagnostic performance of fluorescence optical imaging measuring synovitis in hand osteoarthritis: baseline results from the Nor-Hand cohort. 61
33731167 2021
31
Diagnostic challenge of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome in pediatric age: A monocentric case series. 61
33627034 2021
32
Histologic evidence for a humoral immune response in synovitis associated with cranial cruciate ligament disease in dogs. 61
33769592 2021
33
Long-term functional outcomes of diffuse pigmented villonodular synovitis of knee: The role of adjuvant radiotherapy. 61
33761628 2021
34
Correlation between Severity of Synovitis and Clinical Features in Rotator Cuff Tears. 61
33747384 2021
35
Fluoroquinolone exposure in utero did not affect articular cartilage of resulting foals. 61
32479667 2021
36
[Postinfectious reactive arthritis after chlamydia infection in competitive sports : Clinical management and current literature review]. 61
32583060 2021
37
Classifying Pseudogout Using Machine Learning Approaches With Electronic Health Record Data. 61
31910317 2021
38
Ultrasound assessment of carpal tunnel in rheumatoid arthritis and idiopathic carpal tunnel syndrome. 61
32696282 2021
39
Thoracic outlet syndrome in a patient with SAPHO syndrome - A case report. 61
33667913 2021
40
Prevalence of anti-cyclic citrullinated peptide antibodies in patients with spondyloarthritis: A retrospective study. 61
32340503 2021
41
Novel insights into macrophage diversity in rheumatoid arthritis synovium. 61
33476818 2021
42
Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview. 61
33802804 2021
43
Capillaroscopy as a diagnostic tool in the diagnosis of mixed connective tissue disease (MCTD): a case report. 61
33736700 2021
44
The New Bern Chondrolabral Classification Is Reliable and Reproducible. 61
33787519 2021
45
Prognostic Factors for Radiographic Progression in Patients with Seronegative Rheumatoid Arthritis. 61
33807932 2021
46
[Effect of moxibustion at "Zusanli"(ST36) and "Shenshu"(BL23) on miR-155-mediated TLR4/NF-κB signaling involving amelioration of synovitis in rheumatoid arthritis rats]. 61
33798291 2021
47
Histopathologic Features of Fibrotic Knee Synovitis in a Young Adult With Seronegative Rheumatoid Arthritis. 61
31876841 2021
48
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis. 61
33750008 2021
49
Laser speckle contrast analysis in rheumatoid arthritis: a pilot study. 61
33686937 2021
50
Fibrocytes in early and long-standing rheumatoid arthritis: a 6-month trial with repeated synovial biopsy, imaging and lung function test. 61
33674419 2021

Variations for Plica Syndrome

Expression for Plica Syndrome

Search GEO for disease gene expression data for Plica Syndrome.

Pathways for Plica Syndrome

GO Terms for Plica Syndrome

Molecular functions related to Plica Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 serine-type endopeptidase activity GO:0004252 8.62 PLGLB2 MMP3

Sources for Plica Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....